Quality of life (QoL) in patients (pts) with locally advanced or metastatic breast cancer (MBC) previously treated with anthracyclines and taxanes who received eribulin mesylate or capecitabine: A phase III, open-label, randomized study.

More by Javier Cortes :
  1. Meeting: 2015 ASCO Annual Meeting
    Session: Breast Cancer-HER2/ER (Poster Discussion Session)
    Discussant: Javier Cortes